2023 BioTech Drug Development Health Information 
Society for Participatory Medicine
FEBRUARY 1, 2023
The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen. This hasn’t been made clear yet due in part to the fourth and final guidance session on clinical outcome assessment data yet to occur in 2023.
Healthcare IT Today
JANUARY 8, 2024
The excitement around new tools took hold of all industries in 2023, and the potential is expansive. In 2023, Pear Therapeutics filed for bankruptcy and Akili abandoned the prescription business model. Health Economics Outcomes Research (HEOR) will become more common in decentralized clinical trials (DCTs).
Expert insights. Personalized for you.
144 
Let's personalize your content